Odysight.ai is an Israeli-rooted, Nevada-listed visual sensing company trying to turn a medical-camera heritage into a defense and aerospace predictive-maintenance franchise. The first half of the year produced the logos the equity has been waiting for, including a first direct purchase order from Boeing and a Honeywell Aerospace auxiliary-power-unit proof of concept, while recognized revenue stayed tiny. The investment debate is whether those original-equipment doors are the start of a production franchise or another lap of demonstration work that still burns cash faster than it converts booked orders.
Mid-year cash sat near $18 million with no bank debt. Booked orders stood at $16 million before the August add-ons from Boeing and Elbit Systems. First-half revenue of $502 thousand collapsed versus the prior-year comparison because last year's print still carried a Fortune 500 medical contract and a large liability release. Operating expenses stayed near last year's level, so the half still produced a double-digit million operating loss. The income statement is still a development budget with a thin commercial overlay.
In August the company closed an $11 million common-stock offering at a price that sat on top of the then-prevailing quote and retired the unused at-the-market facility. Shares last changed hands in the low-three range, capitalizing the equity near $56 million on the pre-deal share count and well below last year's double-digit peak. The open question is whether booked work converts into recognized revenue fast enough that this raise is the last large primary, or whether demonstration work keeps sending the company back to the market.